Efficacy and Safety of Risperidone Compared With Placebo in the Treatment of Psychotic Symptoms in Patients With Alzheimer's Disease

NCT00034762 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

473

Enrollment

INDUSTRY

Sponsor class

Conditions

Dementia
Alzheimer Disease
Mental Disorders

Interventions

DRUG: risperidone

Sponsor

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.